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Objective: Prior research suggests an acutely elevated risk of myocardial infarction and sudden
cardiac death in the hour after coffee intake. However, the risk of ischemic stroke associated with
transient exposure to coffee remains unclear. We hypothesized that caffeine intake is associated
with a transiently increased risk of ischemic stroke.
Methods: In this multicenter case-crossover study, we interviewed 390 subjects (209 men, 181
women) between January 2001 and November 2006 a median of 3 days after acute ischemic
stroke. Each subject’s coffee consumption in the hour before stroke symptoms was compared
with his or her usual frequency of consumption in the prior year.
Results: Of the 390 subjects, 304 (78%) drank coffee in the prior year, 232 within 24 hours and
35 within 1 hour of stroke onset. The relative risk (RR) of stroke in the hour after consuming coffee
was 2.0 (95% confidence interval [CI], 1.4–2.8; p  0.001). There was no apparent increase in
risk in the hour following consumption of caffeinated tea (RR  0.9, 95% CI 0.4–2.0; p  0.85) or
cola (RR  1.0, 95% CI 0.4–2.4; p  0.95). The association between ischemic stroke in the hour
after coffee consumption was only apparent among those consuming 1 cup per day but not for
patients who consumed coffee more regularly (p for trend  0.002). Relative risks remained
similar when the sample was restricted to those who were not simultaneously exposed to other
potential triggers and the results remained significant after stratifying by time of day.
Conclusion: Coffee consumption transiently increases the risk of ischemic stroke onset, particu-
larly among infrequent drinkers. Neurology® 2010;75:1583–1588
GLOSSARY
CI  confidence interval; MI  myocardial infarction; RR  relative risk; TOAST  Trial of Org 10172 in Acute Stroke
Treatment.
Approximately 795,000 new or recurrent cases of stroke occur each year. Cerebrovascular
disease is a leading cause of serious, long-term disability in the United States and it is the third
leading cause of mortality, accounting for approximately 1 of every 17 deaths in the United
States in 2005. The estimated direct and indirect cost of stroke for 2009 is $68.9 billion.1
Coffee has been documented to have acute deleterious physiologic effects within hours after
consumption, including elevated levels of (nor)epinephrine,2 increased systolic and diastolic
blood pressure3 and vascular resistance,4 and a slight drop in heart rate.3 Compared to decaf-
feinated coffee, consumption of caffeinated coffee acutely increases arterial stiffness5,6 and
impairs endothelium-dependent vasodilation.7 Caffeine has also been shown to eliminate the
protective effect of ischemic preconditioning.8 There is evidence of an acutely elevated risk of
acute myocardial infarction9 and sudden cardiac death10 in the hour after coffee intake, but to
our knowledge, there has not been any research to examine the risk of ischemic stroke associ-
ated with transient exposure to caffeine and whether the risk varies by the sources of caffeine.
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Our primary objective was to examine the
association between caffeinated coffee con-
sumption and the risk of acute ischemic
stroke in the subsequent hour.
METHODS Study design. The Stroke Onset Study used a
case-crossover design, a variation of a case-control design that is
appropriate when a brief exposure (caffeinated coffee consump-
tion) causes a transient change in the risk of an acute outcome
(ischemic stroke).11,12 We compared a subject’s coffee consump-
tion in the hour prior to onset of stroke symptoms (the case
period) with the same subject’s usual frequency of coffee con-
sumption in the prior year (the control period). Because control
information for each subject is based on his or her own past
exposure experience, self-matching eliminates confounding by
risk factors that are constant within individuals over the sam-
pling period but often differ between study subjects.
Study population. The Stroke Onset Study was conducted in 3
medical centers (Beth Israel Deaconess Medical Center, Boston,
MA; University of North Carolina Hospitals, Chapel Hill, NC;
Vancouver Island Health Authority, Victoria, BC) between January
2001 and November 2006. Trained research staff identified eligible
subjects by reviewing admission logs and charts of subjects admitted
to each hospital’s stroke service. Additionally, subjects with new on-
set of an acute neurologic syndrome compatible with stroke were
screened upon admission to emergency departments. Presumed
stroke etiology was determined according to an abbreviated Trial of
Org 10172 in Acute Stroke Treatment (TOAST) classification sys-
tem.13 Across all sites, 43% of patients with confirmed ischemic
stroke met all inclusion criteria. Of these, 83% agreed to participate,
5.5% refused, and the remaining 12.5% were discharged from the
hospital before the interviewers were able to approach them. The
final sample includes 390 subjects (209 men and 181 women) who
were interviewed a median of 3 days (range 0–14) after sustaining
an acute ischemic stroke.
For each case, trained study personnel using standardized
abstraction forms recorded data on demographics, medical his-
tory, and admission laboratory results. To be eligible, subjects
were required to have a neurologist-confirmed diagnosis of acute
ischemic stroke, either by clinical diagnosis or appropriate imag-
ing studies, to be English-speaking, and to be free of dementia
prior to the index event. Subjects were excluded if they were
unable to complete the structured interview because they were
cognitively impaired, had poor memory around the time of the
stroke, could not identify the time of onset of their stroke symp-
toms, experienced aphasia, or were too ill to complete the struc-
tured interview that lasted 30 to 45 minutes.
Coffee consumption. Interviewers used a structured question-
naire and asked subjects if they had consumed any coffee in the year
preceding their stroke. Subjects who reported any coffee consump-
tion were also asked to report the last time that they had consumed a
serving of coffee and their usual frequency of coffee consumption
over the prior year. The portion size for 1 serving of coffee was
defined as 8 ounces or 1 cup of caffeinated coffee. Similar ques-
tions were asked about consumption of caffeinated tea and cola.
Subjects were also asked to report the timing of their last expo-
sure to other potential triggers and usual frequency of these fac-
tors in the year preceding the onset of stroke symptoms. Other
information collected from the interview included medication
use and symptoms on the day of the stroke.
Reliability of the questionnaire. The test-retest reliability
of the Stroke Onset Study questionnaire was assessed in a sub-
group of 25 subjects who were re-interviewed up to 6 days after
their initial interview and asked again about their coffee con-
sumption patterns in the past year as well as the time of their last
drink before the onset of their stroke symptoms. The intraclass
correlation for the usual frequency of coffee consumption was
found to be excellent (0.96), and there was high agreement for
reporting of any coffee consumption during the past year ( 
0.96) and during the hour preceding stroke onset (  0.88).
Standard protocol approvals, registrations, and patient
consents. The protocol was approved by the institutional re-
view board at each participating center and written informed
consent was obtained from all subjects participating in the study.
Statistical analysis. Each subject in a case-crossover study
forms his or her own stratum and thus is his or her own con-
trol.11,12 The ratio of the observed exposure frequency in the case
period to the expected frequency based on control information
about coffee consumption in the previous year was used to calcu-
late estimates of the rate ratio as a measure of relative risk (RR).
We multiplied the usual annual frequency of coffee consump-
tion by the hypothesized window of its physiologic effect (1 hour
in the primary analysis) to estimate the amount of person-time
exposed to coffee. The unexposed person-time was calculated by
subtracting this value from the number of hours in 1 year. The
data were analyzed using methods for cohort studies with sparse
data in each stratum. Similar analyses were conducted for caf-
feinated tea and caffeinated cola.
To estimate the length of time from coffee consumption to
the onset of ischemic stroke, RRs were calculated for each 1-hour
period before stroke onset. We stratified by sex, age (65, 65–
75, and 75 years), smoking status (never, former, current),
habitual moderate or vigorous physical activity (3 or more times
per week vs fewer than 3 times per week), and stroke etiology
and compared the RRs by means of a test for homogeneity.14
Thirty-two subjects were excluded from the analysis stratified by
stroke etiology because it was not determined at 1 center. We
stratified by intake of coffee in the past week (up to 1 cup per
day, more than 1 to 3 cups per day, more than 3 cups per day)
and conducted a test for trend.15 Because there is a circadian peak
of stroke onset in the morning hours16 and people tend to drink
more coffee in the morning than during the rest of the day, we
conducted a sensitivity analysis which we restricted to subjects
experiencing strokes between 6 AM and 9 AM. We made the con-
servative assumption that all coffee in the past year is only con-
sumed during that time of day, which should result in a
conservative estimate of the RR. To evaluate whether potential
triggers could account for the observed association, we con-
ducted a sensitivity analysis excluding subjects simultaneously
exposed to other potential triggers (e.g., vigorous physical exer-
tion, alcohol, marijuana, and anger) in the hour preceding their
stroke and a sensitivity analysis excluding subjects reporting a
stroke or myocardial infarction (MI) within the year preceding
the index event. In another sensitivity analysis, we used the num-
ber of servings of coffee consumed in the week preceding the
stroke as the control information. All reported p values are
2-sided.
RESULTS The characteristics of the Stroke Onset
Study subjects are presented in the table. Of the 390
subjects with acute ischemic stroke who were inter-
viewed, 305 (78%) reported that they had consumed
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coffee in the prior year. One subject provided no
information about usual coffee intake, so the subject
was excluded from all analyses. Compared to non-
drinkers, subjects who reported coffee consumption
within the past year were more likely to be current
smokers and they were less likely to have a history of
atrial fibrillation. Among the 304 subjects who drank
coffee in the prior year, 249 (82%) drank at least 1
serving of coffee per day, 35 (12%) drank at least
once per week, 13 (4%) drank coffee at least once per
month, and 7 (2%) drank coffee less than once per
month; the median frequency of consumption was 7
times per week. Thus, the average amount of person-
time exposed to coffee in the prior year (the control
period) was 364 hours per subject.
Among the 304 subjects who drank coffee in the
prior year, 35 subjects consumed at least 1 serving of
coffee within 1 hour of the onset of stroke symptoms
(the case period). We found that within 1 hour after
coffee consumption, the risk of stroke onset was 2.0-
fold higher (95% confidence interval [CI] 1.4–2.8;
p  0.001) compared with periods of nonuse, and it
rapidly returned to baseline thereafter. The risks of
ischemic stroke in the hour following consumption
of caffeinated tea (RR  0.9, 95% CI 0.4–2.0; p 
0.85) or cola (RR  1.0, 95% CI 0.4–2.4; p  0.95)
were not elevated (figure 1). The RRs for coffee con-
sumption did not vary by sex (p  0.13), age (p 
0.56), smoking status (p  0.22), physical activity
(p  0.44), or stroke etiology (p  0.29). When we
stratified by daily intake of caffeinated coffee in the
past week, the association between ischemic stroke in
the hour after coffee consumption was only apparent
among those consuming 1 or fewer cups per day but
not for patients who consumed coffee more regularly
(p for trend  0.002; figure 2).
In a sensitivity analysis using the conservative as-
sumption that all coffee in the past year is only con-
sumed in the morning (6 AM–9 AM), coffee
consumption was still associated with an increased
risk of ischemic stroke onset (RR  3.8, 95% CI
2.0–7.0; p  0.001). Among the 304 subjects ex-
posed to coffee in the prior year, 75 subjects were
exposed to other potential triggers in the hour prior
to stroke onset. Of the 35 people exposed to coffee in
the hour prior to stroke onset, 3 were also exposed to
vigorous physical activity, 1 experienced feelings of
anger, 1 smoked a cigarette, and 1 drank an alcoholic
beverage. When we conducted an analysis excluding
the 75 people exposed to any potential stroke trigger
in the hour preceding stroke onset, the results re-
mained similar. RRs were similar when the sample
was restricted to those who did not experience a
stroke or MI in the prior year (n  283). On average,
subjects reported almost identical levels of coffee
consumption in the week preceding the stroke and in
the prior year, so the RR did not change when we
used each subject’s reported frequency of consump-
tion in the past week to estimate control periods.
Figure 1 Relative risk of ischemic stroke within 1 hour according to the
beverage type
The error bars indicate the 95% confidence limits. The dashed line indicates the baseline risk.




(n  85) p Value
Age, y 68.1  14.3 70.0  13.9 0.26
Men 169 (56) 39 (46) 0.11
Smoking status 0.0001
Never 84 (28) 44 (52)
Former 152 (50) 33 (39)
Current 68 (22) 8 (10)
Obesity (body mass index
>30 kg/m2)b
73 (25) 16 (19) 0.30
Diabetes 75 (25) 19 (22) 0.66
Hypercholesterolemia 117 (38) 29 (34) 0.46
Hypertension 197 (65) 55 (65) 0.99
Atrial fibrillation 34 (11) 20 (24) 0.004
History of:
Myocardial infarction 39 (13) 10 (12) 0.79
Stroke 60 (20) 13 (15) 0.35
TIA 38 (13) 9 (11) 0.63
Coronary revascularization 29 (10) 12 (14) 0.22
Carotid endarterectomy 7 (2) 0 (0) 0.16
Stroke etiologyc 0.52
Small vessel 88 (32) 23 (30)
Large vessel 55 (20) 12 (16)
Cardioembolic 58 (21) 22 (29)
Other/undetermined 79 (28) 20 (26)
a Values are mean  SD or n (%).
b There were no data available on body mass index for 7 subjects.
c At one of the centers, stroke etiology was not determined (n  32).
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DISCUSSION In this study, we found that coffee
consumption was associated with a transient risk of
ischemic stroke in the subsequent hour that was 2.0
times higher than the risk during periods with no
coffee consumption, and the risk returned to baseline
by 2 hours. Our findings are consistent with 2 case-
crossover studies on coffee intake and other acute
cardiovascular events.9,10 In a study of 503 incident
cases of nonfatal myocardial infarction,9 the RR of
acute myocardial infarction in the hour after coffee
intake was 1.5 (95% CI 1.2–1.9), and the association
was particularly strong for those who are only occa-
sional coffee drinkers, those with 3 or more cardio-
vascular risk factors, and those who lead sedentary
lifestyles. A similar study10 reported that the RR of
dying from sudden cardiac death within an hour af-
ter drinking a cup of coffee was 73% higher (95% CI
1.1–2.7) than periods with no coffee consumption.
Similar to the prior study of myocardial infarction,9
we found that the effect of coffee consumption was
not significantly different in men vs women, subjects
older or younger than 65 years of age, or by smoking
status, frequency of habitual physical activity, or
stroke etiology.
We did not find an association between con-
sumption of caffeinated tea or cola and ischemic
stroke. The lower dose of caffeine in these beverages
may account for this difference.17
Evidence from experimental studies indicates that
coffee acutely increases circulating concentrations of
(nor)epinephrine,2 raises systolic and diastolic blood
pressure,3 increases arterial stiffness,5,6 and impairs
endothelium-dependent vasodilation.7 Some studies
have shown that habitual consumption results in a
tolerance to the acute effects of caffeine,18,19 while
others have found that some individuals continue to
experience these acute effects with each drinking epi-
sode20,21 and that the tolerance disappears after 12
hours of abstinence.22 This is consistent with our
findings and others,9 indicating that the RR of isch-
emic stroke in the hour following consumption of
caffeinated coffee was higher among people reporting
lower levels of habitual coffee consumption.
There have been discrepant findings on the asso-
ciation between habitual coffee intake and ischemic
stroke. One study found that total coffee consump-
tion was not associated with an increased stroke risk
in men23 and another study found that coffee con-
sumption was associated with an increased risk of
ischemic stroke among hypertensive men who re-
ported no previous or current smoking.24 However,
others have reported that habitual coffee consump-
tion is associated with a lower risk of ischemic stroke.
In the Alpha-Tocopherol, Beta-Carotene Cancer
Prevention Study of men, smokers who drank 8 or
more cups of coffee per day had a 23% lower risk of
stroke than those who drank fewer than 2 cups per
day.25 Similarly, in the Nurses’ Health Study, women
who drank 4 or more cups of coffee per day had a
20% lower risk of stroke than those who did not
consume coffee.26 These results are concordant with
our finding of no increased risk among those who
drink coffee regularly, suggesting that habitual con-
sumption results in a tolerance to the acute effects of
caffeine.18,19
There are some limitations to our study that war-
rant discussion. Based on previous research, our a
priori hypothesis was focused on caffeinated coffee
consumption so we did not collect information on
the coffee type or preparation method or on con-
sumption of decaffeinated beverages. Since the case-
crossover design uses subjects as their own controls,
there is no variability in traditional risk factors for
stroke.11 However, confounding by factors that
change over time within individual subjects can oc-
cur if other transient risk factors occur during the
case period of interest. In a sensitivity analysis using a
conservative assumption that all coffee in the past
year was consumed in the morning, the results re-
mained significant. Though there may be residual
confounding by time of day, this suggests that the
findings are not fully explained by the co-occurrence
of coffee and the circadian peak in stroke onset. A
sensitivity analysis excluding subjects reporting other
potential triggers in the hour preceding stroke onset
did not materially alter the results. We had limited
power to determine whether the effect of coffee con-
sumption varied by clinical characteristics or stroke
etiology.
Recall bias may occur if there is systematic error
in reporting usual exposure frequency compared
Figure 2 Relative risk of ischemic stroke within 1 hour by drinking frequency
in the prior week
The error bars indicate the 95% confidence limits. The dashed line indicates the baseline risk.
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with exposure during the hour before stroke onset.11
If subjects overestimate exposure in the period im-
mediately before the stroke and underestimate expo-
sure in the past year, the RR may be biased upwards.
In an effort to minimize reporting bias and to main-
tain subject confidentiality, efforts were made to en-
sure the subject’s privacy during the interview. We
used a standardized structured interview and subjects
were not informed of the duration of the hypothe-
sized case period. If patients whose strokes were trig-
gered by coffee consumption were more likely to
participate or had milder strokes than those whose
strokes were unrelated to coffee, the apparent RR
might be overestimated. The patients we interviewed
tended to have milder strokes, as those with aphasia,
memory difficulties, or severe strokes leaving them
incapacitated or too ill to be interviewed were ex-
cluded from the study. Therefore, our results may
not be generalizable to subjects presenting with a se-
vere or fatal stroke. However, the RR for recent cof-
fee consumption did not vary by stroke etiology,
suggesting that the role of coffee as a stroke trigger
does not differ by stroke mechanism and is unlikely
to vary by severity.
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